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Abstract 
Mucormycosis is caused by fungi of the order Mucorales and is one of the fulminant and fatal mycotic infections 
known to human beings with a high mortality rate. Rhinocerebral mucormycosis is the most common type and its 
extension to the orbit and brain is quite usual. It is commonly reported in immunocompromised patients such as po-
orly controlled diabetes mellitus, blood dyscrasias, malnutrition, neutropenia, iron overload, organ transplant, and 
immunosuppressive therapy. Mucormycosis is on the rise with an increase in incidence of Diabetes mellitus and 
HIV infection leading to immunocompromised status of the patient. Here in, reporting two cases of rhinocerebral 
mucormycosis in two uncontrolled diabetic patients with deep palatal perforation in one case and this is a rare and 
late occurrence. Both the patients were successfully treated with a combination of surgical debridement and syste-
mic amphotericin B administration. By presenting this case report we would like to point out that mucormycosis 
should be included in the differential diagnosis of hard palate ulcers and cellulitis.
Key words: Fungal infection, mucorales, immunocompromised status, palatal perforation, diabetes mellitus.
Sujatha RS., Rakesh N.,Deepa J., Ashish L., Shridevi B. Rhino cerebral 
mucormycosis. A report of two cases and review of literature. J Clin Exp 
Dent. 2011;3(3):e256-60.
http://www.medicinaoral.com/odo/volumenes/v3i3/jcedv3i3p256.pdf
Article Number: 50377              http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
e257
J Clin Exp Dent. 2011;3(3):e256-60.                                                                     Rhino Cerebral Mucormycosis.
Introduction
Mucormycosis (Zygomycosis) is a rare, opportunistic 
fungal infection, occasionally fatal caused by mucorales, 
belonging to the class of zygomycetes (phycomycetes) 
(1) This fungus is widespread and occurs in soil, manu-
re, vegetable, fruits and as bread mold. The incidence of 
mucormycosis is approximately 1.7 cases per 1,000,000 
inhabitants per year.(2) Depending on the immunologi-
cal status of the patient, the disease may manifest in six 
different ways depending on the affected site as rhino-
cerebral, pulmonary, cutaneous, gastrointestinal, central 
nervous system or disseminated forms. Patients with 
diabetes mellitus usually have the rhinocerebral and pul-
monary forms of the disease (3). Diagnosis is confirmed 
by histopathological demonstration of the organism in 
the affected tissue (4). Early diagnosis and treatment of 
mucormycosis is extremely important due to the aggres-
sive course of the disease. Control of underlying disease 
must be established, metabolic abnormalities corrected 
and antifungal therapy should be combined with surgical 
debridement of all necrotic tissues (5). 
Herein, reporting two cases of rhino cerebral mucor-
mycosis which were treated by a combined approach 
involving, medical and surgical management. 
Case Report
Case Report 1
A 65 year old female patient reported to the dental de-
partment with a complaint of nasal regurgitation of food 
associated with a purulent discharge from the nasal ca-
vity and right eye for the past 15 days (Fig .1). Patient 
noticed drooping of her upper right eyelid and complete 
closure of her right eye associated with fever and pain 
on the right side of the face (Fig.1). Patient is a known 
diabetic and hypertensive since 10 years with a history 
of poor drug compliance. Patient was poorly built and 
debilitated, confused, disoriented and foul smelling. 
There was ptosis; complete drooping of her right upper 
eyelid with purulent discharge and inability to separa-
te the eyelids. Based on these findings a diagnosis of 
right eye panopthalmitis was given.  Examination of the 
nasal cavity revealed eschar of the right nasal septum 
with exposure of bone. Intraorally 3x2 cm circular per-
foration was noticed in the anterior region of the hard 
palate through which a blackish, necrotic hemorrhagic 
mass was seen (Fig.2).  A through and through opening 
was formed due to perforation in the palate creating an 
oronasal fistula. Submandibular lymphadenopathy was 
present. Based on the history and clinical presentation, 
a provisional diagnosis of mucormycosis was made 
and gummatous necrosis, midline lethal granuloma and 
Wegener’s granulomatosis were considered under diffe-
rential diagnosis. Patient was subjected to various bio-
chemical investigations (Table 1).
Fig. 1.Complete drooping of upper eyelid with pus 
discharge
Fig 2. Perforation in the right anterior region of the hard palate
Random blood sugar 419mg/dl
Hemoglobin 9.6 gm%
Packed cell volume 32%
Ketone bodies Negative
CSF examination
Glucose 
Protein 
Chlorine
155mg%
53mg%
127 meq/l
HIV negative
CSF – Cerebrospinal Fluid
HIV-Human Immunodeficiency Virus
Table 1. Biochemical investigations of case 1
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moderately built and nourished and vital signs were wi-
thin the normal range. 
Extraoral examination revealed a diffuse swelling on the 
left half of the face with periorbital edema. On palpation 
the swelling was tender, febrile and soft in consistency. 
Submandibular lymphadenopathy was noticed. Exami-
nation of left eye revealed diminished vision, ptosis, 
proptosis, dilated pupil, and restricted eye movement su-
ggestive of involvement of 2nd, 3rd, 4th and 6th cranial 
nerves (Fig. 4).Intraoral examination revealed bad oral 
hygiene, generalized gingival recession, attrition, and 
cervical abrasion. Based on history and clinical exami-
nation, a working diagnosis of cellulitis was given and 
canine space infection and cavernous sinus thrombosis 
were considered under differential diagnosis. Blood su-
gar and other investigations were carried out (Table 2). 
Occlusal radiograph showed an ill-defined radiolucency 
in the anterior region of the hard palate (Fig.3). Water’s 
view showed diffuse haziness of the right maxillary si-
nus with evidence of destruction of floor of the sinus. 
Magnetic resonance imaging (MRI) did not show any 
significant changes. Scrapings of conjunctiva, nasal ca-
vity and palate were sent for histopathological examina-
tion.  The histopathological report revealed nonseptate 
hyphae branched at right angle in areas of exudate and 
granulation tissue, a feature of deep fungal infection.
Surgical, Ear Nose Throat (ENT), neurological and 
histopathologic report concurred with the diagnosis of 
rhino cerebral mucormycosis. Emergency medical ma-
nagement of diabetes was started by administration of 
insulin which resulted in optimal glycaemic control. The 
patient was started on intravenous amphotericin B 50 mg 
in 3 divided doses and  metronidazole 1gm intravenously 
every 12 hourly. Patient was transfused with 1 unit of 
packed cells after blood grouping and cross matching. 
Evisceration procedure of the right eye was performed 
after monitoring blood glucose levels and other vital 
signs. Surgical debridement of necrotic tissues of nasal 
wall and palate was done following which an obturator 
was constructed for the patient. Thus, with a combined 
approach of dental, ophthalmological, surgical and ENT 
team the case was successfully treated. The patient was 
advised daily administration of insulin and to maintain 
glycaemic control, scrupulous oral and general hygiene. 
Patient is under follow up.  
Case Report 2
A 57 year old male patient, farmer by profession repor-
ted with a complaint of pain in the left upper and lower 
jaw since a month and swelling on the left side of the 
face since three weeks. Pain was continuous, throbbing 
in nature, radiating to the head and neck region, which 
was relieved on taking over the counter analgesics. In-
termittent blood- tinged nasal discharge since 1 week 
was reported. Patient was a known diabetic since 7 years 
and was on insulin therapy 40 IU once a day. He was 
Fig. 3. Occlusal radiograph showing ill-defined radiolucency in the 
anterior region of the hard palate
Fig. 4. Dilated pupil of the left eyeeye  
Random blood sugar 392 mg/dl
Hemoglobin 12 gm%
RBC 4.6 millions/mm3
WBC 7,000/ML
Differential count
Neutrophils Lymphocytes
Eosinophils 
Basophils 
Monocytes 
62
23
2
0
3
HIV negative
WBC-White Blood Cells
HIV-Human Immunodeficiency Virus
Table 2. Biochemical investigations of case 2
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Paranasal sinus view revealed haziness on left maxillary 
sinus region.  MRI suggested ethmoid, frontal, and maxi-
llary sinus opacification (Fig.5).Patient was referred to 
department of ophthalmology for eye examination and 
department of otolaryngology for further evaluation 
where functional endoscopic sinus surgery was perfor-
med and tissue specimen was sent for the histopatho-
logic examination. It revealed broad non-septate fungal 
filaments with branching at right angles. Based on the 
above findings a final diagnosis of the rhino orbital-ce-
rebral mucormycosis was given.
Human mixtard 40 IU/ml and Human actraped 40 IU/ml 
was administered till blood glucose levels were within 
the normal range. Debridement of sinus was done and 
parenteral Ceftriaxone 1gm, amikacin 500 mg and am-
photericin B 50 mg diluted in 500 ml normal saline per 
day was prescribed for 7 days and injection amphoteri-
cin B 50 mg once a day for 3 months was advised. Nasal 
wash with saline was advised for a week. His condition 
improved dramatically and is under follow up.
Discussion
 Mucormycosis infection in humans is usually acquired 
through airborne fungal spores, contamination of trau-
matized tissue, ingestion and direct inoculation (6).For 
optimal growth in humans, mucorales fungi require the 
host to have decreased levels of neutrophils, since they 
play a key role in defense against the fungi. In healthy 
individuals neutrophils phagocytose these pathogens 
whereas in neutropenic individuals such as in chemothe-
rapy patients or malignancy, pathogens proliferate in the 
host tissue and infection ensues (7).  
 While mucormycosis has been reported in otherwise 
healthy individuals; a predisposing medical condition 
is virtually always present. Both our patients had un-
controlled diabetes which is a well-known predisposing 
factor for mucormycosis. Uncontrolled diabetes mellitus 
can alter the normal immunologic response of patients to 
infections. The number of spores also  rapidly increase 
in carbohydrate-rich environment .Such patients have 
decreased granulocyte phagocytic ability with altered 
polymorphonuclear leukocyte response (8).Diabetes 
mellitus is most common and is associated with 40% of 
mucormycosis cases overall and 70% of patients with 
rhino cerebral mucormycosis (7). 
Rhino cerebral mucormycosis usually begins in the nasal 
mucosa or palate and extends to the paranasal sinuses, 
spreading via the angular, lacrimal, and ethmoid vessels 
as well as by direct extension from the sinuses into the 
retro-orbital region. Once fungal hyphae enter into the 
blood stream they can disseminate to other organs such 
as cerebrum or lungs which can be fatal for the patient.
Mucor hyphae form thrombi within the blood vessels 
which reduce vascularity to the tissues and cause ne-
crosis (9).Thrombosis of the internal maxillary artery or 
sphenoplatine artery caused by mucormycotic infection 
as well as immunocompromised state due to  chronic 
uncontrolled  diabetes in our  second patient  may have 
resulted in palatal perforation and necrosis of the right 
nasal septum.  With orbital involvement, function of the 
cranial nerves II, III, IV and VI may be lost or impaired, 
with resultant proptosis, ptosis, papillary dilation, visual 
loss as well as periorbital cellulitis. Typical clinical pre-
sentation includes facial pain, presence of an irregular 
black eschar on the palatal or nasal mucosa and drainage 
of pus from the eye and nose (10).All these findings are 
consistent with both our cases and are suggestive of rhi-
no cerebral mucormycosis. 
Radiographically, rhinocerebral mucormycosis has been 
Fig. 5. T2 weighted image shows hyperintense region in ethmoid sinus   and maxillary sinus                                     
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associated with nodular thickening of sinus mucosa, sin-
us opacification without fluid levels, and spotty destruc-
tion of the bony walls of paranasal sinuses. It has been 
suggested that any diabetic patient in a ketoacidotic state 
who presents with clinical and radiographic findings of 
rhino sinusitis should be suspected as having mucor-
mycosis until proven otherwise (11).
Early diagnosis and treatment are of extreme importan-
ce for successful eradication of infection and for patient 
survival. For a definitive diagnosis of mucormycosis, 
the histopathological specimen need not be of the iso-
lated fungus, but may be a sample of the necrotic tissue 
from the site in question. The Grocott-Gomori methe-
namine silver stain is the most effective for identifying 
fungi. However, haemotoxylin and eosin, periodic acid 
schiff or calcofluor white stains may also be used. Inva-
sion of the tissue by fungal non septate hyphae and right 
angle branching is present in mucormycosis specimens. 
Because initial cultures of diseased tissue may be nega-
tive, histopathological examination is essential for early 
diagnosis (10, 12). 
Systemic antifungal therapy includes the use of high 
dose amphotericin-B and is associated with an overall 
survival rate of 72%.Since  its usage is associated with 
renal toxicity and it  requires careful monitoring of serum 
urea nitrogen, blood urea nitrogen potassium , creatini-
ne as well as creatinine clearance as an essential part of 
the therapy. Recently, studies have shown that liposomal 
amphotericin B (where the drug has been inserted into 
liposomes) (13) and fluconazole (14) can be used with 
good success. Hyperbaric oxygen therapy is believed to 
improve neutrophilic killing by higher oxygen delivery 
and delaying or totally inhibiting the growth of fungal 
spores and mycelium (15).Rehabilitation or closure of 
the existing oronasal fistula can be done surgically or by 
construction of a prosthetic appliance. 
Mucormycosis is a rapidly progressive disease with a 
fulminant course and fatal outcome unless diagnosed 
early and treated rapidly. Prognosis is dependent on mul-
tiple factors and early initiation of treatment is an impor-
tant element. A multi-disciplinary approach consisting 
of dental specialists, ENT surgeons, ophthalmologists 
and neurologist is critical in successful management of a 
patient with mucormycosis.
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